A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Panaampon, Jutatip ^a,b   Ngaosuwankul, Nathamon ^b   Suptawiwat, Ornpreya ^a,b   Noisumdaeng, Pirom ^a,b   Sangsiriwut, Kantima ^a   Siridechadilok, Bunpote ^c   Lerdsamran, Hatairat ^a,b   Auewarakul, Prasert ^a,b   Pooruk, Phisanu ^a   Puthavathana, Pilaipan ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEMAGGLUTININ; INNATE SERUM INHIBITOR; SIALIDASE; UNCLASSIFIED DRUG; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; INFLUENZA VIRUS HEMAGGLUTININ; RECOMBINANT PROTEIN; VIRUS ANTIGEN;

2009 H1N1 INFLUENZA; ANIMAL CELL; ANTIVIRAL ACTIVITY; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; AVIAN INFLUENZA; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG SAFETY; GLYCOSYLATION; GUINEA PIG; INFLUENZA A (H5N1); INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INNATE IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; REVERSE GENETICS; SEASONAL INFLUENZA; VIRUS NEUTRALIZATION; VIRUS RESISTANCE; VIRUS STRAIN; ANIMAL; BIRD; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HEAT; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; PATHOGENICITY; PROTEIN TERTIARY STRUCTURE; SERUM; VIROLOGY; VIRULENCE;

AVES; CAVIA; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIGENS, VIRAL; BIRDS; CELL LINE; GLYCOSYLATION; GUINEA PIGS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HOT TEMPERATURE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SERUM; VIRULENCE;

EID: 84860475769     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036318     Document Type: Article

References (41)

1. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, et al. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus (2008) Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 358: 261-273.
2. Peiris JS, de Jong MD, Guan Y, (2007) Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 20: 243-267.
3. Piwpankaew Y, Monteerarat Y, Suptawiwat O, Puthavathana P, Uipresertkul M, et al. (2010) Distribution of viral RNA, sialic acid receptor, and pathology in H5N1 avian influenza patients. APMIS acta pathologica microbiologica et immunologica Scandinavica 118: 895-902.
4. de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, et al. (2005) Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 352: 686-691.
5. Gu J, Xie Z, Gao Z, Liu J, Korteweg C, et al. (2007) H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 370: 1137-1145.
6. Chutinimitkul S, Bhattarakosol P, Srisuratanon S, Eiamudomkan A, Kongsomboon K, et al. (2006) H5N1 influenza A virus and infected human plasma. Emerg Infect Dis 12: 1041-1043.
7. Tse H, To KK, Wen X, Chen H, Chan KH, et al. (2011) Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection. PLoS One 6: e22534.
8. Naficy K, (1963) Human influenza infection with proved viremia-Report of a case. N Engl J Med 269: 964-966.
9. Khakpour M, Saidi A, Naficy K, (1969) Proved viraemia in Asian influenza (Hong Kong variant) during incubation period. Br Med J 4: 208-209.
10. Tsuruoka H, Xu H, Kuroda K, Hosaka Y, (1997) Viremia in influenza: detection by polymerase chain reaction. Nihon Rinsho 55: 2714-2718.
11. Hartshorn KL, White MR, Shepherd V, Reid K, Jensenius JC, et al. (1997) Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol 273 (6 Pt 1): L1156-L1166.
12. Reading PC, Morey LS, Crouch EC, Anders EM, (1997) Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 71: 8204-8212.
13. Leth-Larsen R, Nordenbaek C, Tornoe I, Moeller V, Schlosser A, et al. (2003) Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia. Clin Immunol 108: 29-37.
14. Reading PC, Bozza S, Gilbertson B, Tate M, Moretti S, et al. (2008) Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J Immunol 180: 3391-3398.
15. Horváth A, Andersen I, Junker K, Lyck Fogh-Schultz B, Holm Nielsen E, et al. (2001) Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies. Antiviral Res 52: 43-53.
16. Kase T, Suzuki Y, Kawai T, Sakamoto T, Ohtani K, et al. (1999) Human mannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology 97: 385-392.
17. Job ER, Deng YM, Tate MD, Bottazzi B, Crouch EC, et al. (2010) Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J Immunol 185: 4284-4291.
18. Blue CE, Spiller OB, Blackbourn DJ, (2004) The relevance of complement to virus biology. Virology 319: 176-184.
19. Reading PC, Hartley CA, Ezekowitz RA, Anders EM, (1995) A serum mannose binding lectin mediates complement dependent lysis of influenza virus-infected cells. Biochem Biophys Res Commun 26: 1128-1136.
20. Anders EM, Hartley CA, Reading PC, Ezekowitz RA, (1994) Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. J Gen Virol 75: 615-622.
21. Jayasekera JP, Moseman EA, Carroll MC, (2007) Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J Virol 81: 3487-3494.
22. Cohen A, Belyavin G, (1961) The influenza virus hemagglutination inhibitors of normal rabbit serum: I. Separation of the inhibitory components. Virology 13: 58-67.
23. Krizanová O, Rathová V, (1969) Serum inhibitors of myxoviruses. Curr Top Microbiol Immunol 47: 125-151.
24. Anders E, Hartley C, Jackson D, (1990) Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc Natl Acad Sci U S A 87: 4485-4489.
25. Pritchett TJ, Paulson JC, (1989) Basis for the potent inhibition of influenza virus infection by equine and guinea pig α2-macroglobulin. J Biol Chem 15: 9850-9858.
26. Cwach KT, Sandbulte HR, Klonoski JM, Huber VC, (2012) Contribution of murine innate serum inhibitors toward interference within influenza virus immune assays. Influenza Other Respi Viruses 6: 127-135.
27. Tate MD, Brooks AG, Reading PC, (2011) Specific sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype influenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice. J Immunol 187: 1884-1894.
28. Tate MD, Job ER, Brooks AG, Reading PC, (2011) Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice. Virology 413: 84-92.
29. Hall TA, (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41: 95-98.
30. Steel J, Lowen AC, Wang TT, Yondola M, Gao Q, et al. (2010) Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1: e00018-10.
31. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.
32. Vigerust DJ, Ulett KB, Boyd KL, Madsen J, Hawgood S, et al. (2007) N-linked glycosylation attenuates H3N2 influenza viruses. J Virol 81: 8593-8600.
33. Cherry JL, Lipman DJ, Nikolskaya A, Wolf YI, (2009) Evolutionary dynamics of N-glycosylation sites of influenza virus hemagglutinin. PLoS Curr 1: RRN1001.
34. Vigerust DJ, Shepherd VL, (2007) Virus glycosylation: role in virulence and immune interactions. Trends Microbiol 15: 211-218.
35. Reading PC, Tate MD, Pickett DL, Brooks AG, (2007) Glycosylation as a target for recognition of influenza viruses by the innate immune system. Adv Exp Med Biol 598: 279-292.
36. Auewarakul P, Suptawiwat O, Kongchanagul A, Sangma C, Suzuki Y, et al. (2007) An avian influenza H5N1 virus that binds to a human-type receptor. J Virol 81: 9950-9955.
37. Krug RM, (2006) Virology. Clues to the virulence of H5N1 viruses in humans. Science 311: 1562-1563.
38. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG, (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97: 6108-6113.
39. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR, (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146: 2275-2289.
40. World Health Organization (2002) WHO manual on animal influenza diagnosis and surveillance. Available: http://www.who.int/csr/resources/publications/influenza/en/whocdscsrncs20025rev.pdf. Accessed 13 October 2011.
41. Hawkes RA, (1979) General principle underlying laboratory diagnosis of viral infection. In: Lennette EH, Schmidt NJ, editors. Diagnostic procedures for viral, rickettsial and chlamydial infection, 5th ed Washington DC American Health Association Inc pp. 32-41.